HDAC9 and neoplasm: Recently, HDAC inhibitors have emerged as promising chemotherapeutic agents, and the findings of several studies suggest that they can induce a range of anti-tumor activities including the induction of cell-cycle arrest, the stimulation of differentiation, and the induction of apoptosis in a variety of transformed cells in culture.